Opportunity Information: Apply for RFA DA 19 037
The Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: CNS Data Generation (UM1 Clinical Trial Not Allowed) is a National Institutes of Health (NIH) funding opportunity designed to build high-value single-cell datasets from the central nervous system (CNS). The focus is on generating detailed, cell-by-cell molecular profiles from one or more brain regions that are especially relevant to opioid use disorder and to persistent HIV infection in the brain. Rather than funding a clinical trial, this UM1 cooperative agreement supports coordinated, milestone-driven data generation efforts that can serve as a foundational resource for the broader research community.
At its core, the opportunity aims to produce a granular "cellular parts list" for selected National Institute on Drug Abuse (NIDA)-relevant brain regions. This means cataloging the distinct cell types present in those regions and characterizing how they differ in their gene expression programs at single-cell resolution. By mapping normal and disease-associated cellular states, the program is intended to clarify which specific CNS cell populations are most involved in opioid-related neuroadaptations, HIV-associated neurobiological changes, or the intersection of both conditions.
If successful, the resulting datasets are expected to answer several major questions. First, they should define what cell types exist in targeted brain regions and how those cell types relate to each other molecularly. Second, they should show how chronic opioid exposure reshapes gene expression within specific cell populations, helping researchers pinpoint biological pathways and potential therapeutic targets relevant to opioid addiction. Third, they should reveal how HIV infection in the CNS affects individual cells, which could highlight mechanisms behind HIV-related neurological complications and identify candidate targets to reduce or prevent HIV neurobiological sequelae. Finally, the program explicitly aims to examine whether chronic opioid exposure and HIV infection produce synergistic effects in the CNS, meaning combined impacts that are different from simply adding the effects of each condition alone.
This opportunity is offered as a discretionary grant using the cooperative agreement mechanism, indicating substantial NIH scientific or programmatic involvement during the project period. The funding instrument type is a Cooperative Agreement, and the activity category is listed under Education and Health. The Catalog of Federal Domestic Assistance (CFDA) number associated with the opportunity is 93.279. The funding opportunity number is RFA-DA-19-037, and the title specifies "Clinical Trial Not Allowed," signaling that the proposed work should be centered on data generation and related research activities rather than interventional clinical studies.
Eligibility is broad and includes many types of U.S.-based organizations and governmental units, such as state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; and public housing authorities/Indian housing authorities. It also includes federally recognized Native American tribal governments, as well as Native American tribal organizations that are not federally recognized. Nonprofit organizations are eligible whether or not they have 501(c)(3) IRS status (so long as they are not institutions of higher education under that category). For-profit organizations (other than small businesses) and small businesses may apply as well. The opportunity also highlights additional eligible applicant groups such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations), reflecting an intent to encourage wide participation and data contributions across diverse institutions and settings.
Administratively, the sponsoring agency is the National Institutes of Health. The opportunity was created on 2019-04-01, with an original closing date of 2019-10-08. The award ceiling and the expected number of awards are not specified in the provided source details, which often means applicants would need to consult the full announcement for budget expectations, project period length, milestone structure, and data sharing requirements typically associated with large-scale single-cell data generation efforts.Apply for RFA DA 19 037
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: CNS Data Generation (UM1 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
- This funding opportunity was created on 2019-04-01.
- Applicants must submit their applications by 2019-10-08. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed)
Previous opportunity: Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 19 037
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 19 037) also looked into and applied for these:
| Funding Opportunity |
|---|
| Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach (UM1 Clinical Trial Not Allowed) Apply for RFA DA 19 038 Funding Number: RFA DA 19 038 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed) Apply for RFA DA 19 039 Funding Number: RFA DA 19 039 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) Apply for RFA CA 19 047 Funding Number: RFA CA 19 047 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) Apply for PAR 19 242 Funding Number: PAR 19 242 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Abuse and Addiction Scientists (R25 - Clinical Trials Not Allowed) Apply for PAR 19 246 Funding Number: PAR 19 246 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Limited Competition: Modular Budget Research Project Grant for NIH Nurse Scientist Scholars (R01 Clinical Trial Optional) Apply for PAR 19 256 Funding Number: PAR 19 256 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed) Apply for PAR 19 258 Funding Number: PAR 19 258 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) Apply for PAR 19 259 Funding Number: PAR 19 259 Agency: National Institutes of Health Category: Education, Health Funding Amount: $10,000,000 |
| Limited Competition Cohort Studies of HIV/AIDS and Substance Abuse (U01 Clinical Trial Not Allowed) Apply for RFA DA 20 005 Funding Number: RFA DA 20 005 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional) Apply for PAR 19 264 Funding Number: PAR 19 264 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| HLA and KIR Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed) Apply for RFA AI 19 041 Funding Number: RFA AI 19 041 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional) Apply for PAR 19 277 Funding Number: PAR 19 277 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Blockchain Technology to Improve SUD Care (R43/R44 - Clinical Trial Optional) Apply for RFA DA 20 012 Funding Number: RFA DA 20 012 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Blockchain Technology to Improve SUD Care (R41/R42 - Clinical Trial Optional) Apply for RFA DA 20 011 Funding Number: RFA DA 20 011 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploiting Genome or Epigenome Editing to Functionally Validate Genes or Variants Involved in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed) Apply for PAR 19 278 Funding Number: PAR 19 278 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R01 Clinical Trial Optional) Apply for PAR 19 279 Funding Number: PAR 19 279 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Digital Health Technologies to Address the Social Determinants of Health in context of Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) Apply for RFA DA 20 017 Funding Number: RFA DA 20 017 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R21 Clinical Trial Optional) Apply for PAR 19 280 Funding Number: PAR 19 280 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Digital Health Technologies to Address the Social Determinants of Health in context of Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) Apply for RFA DA 20 018 Funding Number: RFA DA 20 018 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11 Clinical Trials Not Allowed) Apply for PAR 19 285 Funding Number: PAR 19 285 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 19 037", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
